Opsoclonus-Myoclonus Syndrome
"Opsoclonus-Myoclonus Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A neurological condition that is characterized by uncontrolled rapid irregular movements of the eye (OPSOCLONUS) and the muscle (MYOCLONUS) causing unsteady, trembling gait. It is also known as dancing eyes-dancing feet syndrome and is often associated with neoplasms, viral infections, or autoimmune disorders involving the nervous system.
| Descriptor ID |
D053578
|
| MeSH Number(s) |
C04.588.614.550.600 C04.730.856.596 C10.228.758.500 C10.292.562.831 C10.574.781.662 C10.597.350.500.500 C11.590.725
|
| Concept/Terms |
Opsoclonus-Myoclonus Syndrome- Opsoclonus-Myoclonus Syndrome
- Opsoclonus Myoclonus Syndrome
- Dancing Eyes-Dancing Feet Syndrome
- Dancing Eyes Dancing Feet Syndrome
- Opsoclonus Myoclonus Ataxia
- Dancing Eyes, Dancing Feet Syndrome
Kinsbourne Syndrome- Kinsbourne Syndrome
- Myoclonic Encephalopathy of Infants
- Infants Myoclonic Encephalopathies
- Infants Myoclonic Encephalopathy
- Opsoclonus Myoclonus
- Myoclonus, Opsoclonus
|
Below are MeSH descriptors whose meaning is more general than "Opsoclonus-Myoclonus Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Opsoclonus-Myoclonus Syndrome".
This graph shows the total number of publications written about "Opsoclonus-Myoclonus Syndrome" by people in this website by year, and whether "Opsoclonus-Myoclonus Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Opsoclonus-Myoclonus Syndrome" by people in Profiles.
-
Paraneoplastic opsoclonus myoclonus syndrome associated with inflammatory myofibroblastic tumor in a pediatric patient. Pediatr Blood Cancer. 2020 08; 67(8):e28218.
-
Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial. Lancet Child Adolesc Health. 2018 01; 2(1):25-34.
-
Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma. Pediatr Blood Cancer. 2012 Mar; 58(3):472-4.